Chiara Corti/LinkedIn
May 17, 2025, 17:38
Chiara Corti: Decoding Clinical Trials in Metastatic Breast Cancer – Practical Insights for Optimal Therapy Sequencing
Chiara Corti, Oncologist, Research Fellow at Dana-Farber Cancer Institute, shared a post on X:
“NEW ASCO EduBook chapter: Hope Rugo, Sara Tolaney, and I unpack some of the most debated trial design issues in m+ Breast Cancer—suboptimal control arms, crossover challenges, post-progression tx, non-inferiority margins, patient selection, and more.”
Title: Decoding Clinical Trials in Metastatic Breast Cancer: Practical Insights for Optimal Therapy Sequencing
Authors: Chiara Corti, Hope Rugo, Sara Tolaney
You can read the Full Article on ASCO Educational Book.
Bishal Gyawali, Associate Professor at Queen’s University, shared this post, adding:
“I don’t agree with the dismissal of the implications of SONIA and limiting SONIA results only to elderly and frail patients (that’s not SONIA’s population anyway) but am very happy to see these important issues of suboptimal control arms, crossover, post-progression treatments, NI margins etc being discussed.
We need more discussions about these issues in the broader oncology community. More open conversations about this. Enjoyed reading the paper even though I didn’t agree with some sections.”
More posts featuring Chiara Corti.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 17, 2025, 17:21
May 17, 2025, 16:12
May 17, 2025, 16:10
May 17, 2025, 15:37
May 17, 2025, 15:28
May 17, 2025, 15:15